SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-063755
Filing Date
2023-11-14
Accepted
2023-11-14 16:25:40
Documents
6
Effectiveness Date
2023-11-14

Document Format Files

Seq Description Document Type Size
1 S-8 tern-s8-q323.htm S-8 137400
2 EX-5.1 tern-ex5_1.htm EX-5.1 13246
3 EX-23.1 tern-ex23_1.htm EX-23.1 6595
4 EX-FILING FEES tern-exfiling_fees.htm EX-FILING FEES 42242
5 GRAPHIC img60210087_0.jpg GRAPHIC 13640
6 GRAPHIC img60210087_1.jpg GRAPHIC 127709
  Complete submission text file 0000950170-23-063755.txt   395432
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275549 | Film No.: 231406828
SIC: 2834 Pharmaceutical Preparations